MNA (MNA)

The article provides a profile of the MNA ETF (NYLI Merger Arbitrage ETF), detailing its investment strategy, key statistics, holdings, and dividend history. MNA aims to generate returns through a passive merger arbitrage strategy, taking long positions in takeover target stocks, and has an expense ratio of 0.77%. The fund's last dividend payout was $0.38, a decrease from the previous year.

The MNA ETF, issued by New York Life Insurance Co., seeks to generate returns through a passive merger arbitrage strategy by taking long positions in target companies of takeovers. It aims to capitalize on the spread between a target company's current stock price and the buyout price, offsetting long stakes with broad equity indexes to keep correlations low. The ETF has MNA assets under management totaling $246.23 million, with dividend history showing a decrease in its last payout compared to the previous year.

This article details the shareholder structure of Vigil Neuroscience Inc (VIGL), listing its major shareholders and their proportions, including Beryl Capital Management, Amgen Inc, and Glazer Capital, LLC. It also provides a breakdown of shareholder types (Corporation, Venture Capital, Other) and a history of institutional shareholdings from Q1 2023 to Q2 2025, noting changes in the number of institutions and shares held. Additionally, the article lists various ETFs with holdings in VIGL.